Viewing Study NCT00971035


Ignite Creation Date: 2025-12-24 @ 10:10 PM
Ignite Modification Date: 2025-12-25 @ 7:45 PM
Study NCT ID: NCT00971035
Status: COMPLETED
Last Update Posted: 2016-11-29
First Post: 2009-09-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Not Taking Inhaled Corticosteroids
Sponsor: Genentech, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module